Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Bioanalytical Systems, Inc. To Release First Quarter Fiscal 2017 Results On Tuesday, February 14, 2017 February 12, 2017 Why 90% of This $26 Billion Biotech's Sales Could be At Risk Within the Next 2 Years April 20, 2017 Perrigo Shakes Up Exec Roster and Board, Hands Out a Fistful of Pink Slips April 16, 2017
Bioanalytical Systems, Inc. To Release First Quarter Fiscal 2017 Results On Tuesday, February 14, 2017 February 12, 2017
